❌

Normal view

Received today — 7 October 2026 ⏭ Nature Biomedical Engineering

Metal–organic framework nanovaccines for systemic tumour regression

Nature Biomedical Engineering, Published online: 06 October 2026; doi:10.1038/s41551-026-01786-5

A nanoscale metal–organic framework (MOF)-based cancer vaccine platform enables coordinated antigen presentation and innate immune activation, resulting in tumour regression, immune memory and protection against metastasis.
Received — 10 September 2026 ⏭ Nature Biomedical Engineering

Engineering inflammation-responsive proteins through nitric oxide-caged amino acids

Nature Biomedical Engineering, Published online: 31 August 2026; doi:10.1038/s41551-026-01782-9

A protein engineering strategy enables nitric oxide-triggered reactivation of proteins using genetically encoded caged amino acids, allowing inflammation-localized control of protein activity, viral gene delivery and biosensing in vivo.
❌